Evaluation of the humoral immune responses in adult cattle and sheep, 4 and 2.5 years post-vaccination with a bluetongue serotype 8 inactivated vaccine

Vaccine

Volumn 31, Issue 37, 2013, Pages 3783-3785

  Batten, C A ^a   Edwards, L ^a   Oura, C A L ^a,b  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

Bluetongue; Humoral response; Inactivated vaccines; Protection

Indexed keywords

BLUETONGUE SEROTYPE 8 INACTIVATED VACCINE; INACTIVATED VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLUETONGUE; CATTLE; CONTROLLED STUDY; EXPERIMENTAL DESIGN; FOLLOW UP; HUMORAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SHEEP; SINGLE DRUG DOSE; VACCINATION;

BLUETONGUE; HUMORAL RESPONSE; INACTIVATED VACCINES; PROTECTION;

ANIMALS; ANTIBODIES, NEUTRALIZING; BLUETONGUE; BLUETONGUE VIRUS; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; IMMUNITY, HUMORAL; MILK; SHEEP, DOMESTIC; TIME FACTORS; VACCINATION; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 84881557893     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.033     Document Type: Article

References (14)

1. Webb C.R., Floyd T., Brien S., Oura C.A.L., Wood J.L.N. Bluetongue serotype 8 vaccine coverage in Northern and South-eastern England in 2008. Vet Rec 2011, 168:16.
2. Scientific Opinion on bluetongue serotype 8. EFSA J 2011, 9(5):2189. EFSA Panel on Animal Health and Welfare.
3. Eschbaumer M., Hoffmann B., König P., Teifke J.P., Gethmann J.M., Conraths F.J., et al. Efficacy of three inactivated vaccines against Bluetongue virus serotype 8 in sheep. Vaccine 2009, 27(31):4169-4175.
4. Oura C.A.L., Wood J.L.N., Sanders A.J., Bin-Tarif A., Henstock M., Edwards L., et al. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep. Vaccine 2009, 27(52):7326-7330.
5. Bréard E., Belbis G., Hamers C., Moulin V., Lilin T., Moreau F., et al. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats. Vaccine 2011, 29(March (13)):2495-2502.
6. Gethmann J., Huettner K., Heyne H., Probst C., Ziller M., Beer M., et al. Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions. Vaccine 2009, 27(June (31)):4118-4126.
7. Hamers C., Galleau S., Chery R., Blanchet M., Besancon L., Cariou C., et al. Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle. Vet Rec 2009, 165(13):369-373.
8. Wäckerlin R., Eschbaumer M., König P., Hoffmann B., Beer M. Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle. Vaccine 2010, 28(27):4348-4355.
9. Oura C.A.L., Edwards L., Batten C.A. Evaluation of the humoral immune response in adult dairy cattle three years after vaccination with a bluetongue serotype 8 inactivated vaccine. Vaccine 2012, 30(January (2)):112-115.
10. Haig D.A., McKercher D.G., The Alexander R.A. Cytopathic action of Bluetongue virus on tissue cultures and its application to the detection of antibodies in the serum of sheep. Onderstepoort J Vet Res 1956, 27(2):171-177.
11. Eschbaumer M., Eschweiler J., Hoffmann B. Long-term persistence of neutralising antibodies against bluetongue virus serotype 8 in naturally infected cattle. Vaccine 2012, 30(November (50)):7142-7143.
12. Savini G., MacLachlan N.J., Sanchez-Vizcaino J-M., Zientara S. Vaccines against bluetongue in Europe. Comp Immunol Microbiol Infect Dis 2008, 31(2-3):101-120.
13. Verwoerd D.W., Erasmus B.J. Bluetongue. Infectious diseases of livestock 2004, 1201-1220. Oxford University Press, Oxford, UK. 2nd ed. J.A.W. Coetzer, R.C. Tustin (Eds.).
14. Oura C.A.L., Wood J.L.N., Floyd T., Sanders A.J., Bin-Tarif A., Henstock M., et al. Colostral antibody protection and interference with immunity in lambs born from sheep vaccinated with an inactivated Bluetongue serotype 8 vaccine. Vaccine 2010, 28(15):2749-2753.